HEADER HYDROLASE 25-APR-03 1P5C TITLE CIRCULAR PERMUTATION OF HELIX A IN T4 LYSOZYME COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOZYME; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: LYSIS PROTEIN, MURAMIDASE, ENDOLYSIN; COMPND 5 EC: 3.2.1.17; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_TAXID: 10665; SOURCE 4 GENE: GENE E; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: RR1; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHS1403 KEYWDS CIRCULAR PERMUTATION, PROTEIN DESIGN, CONTEXT DEPENDENT FOLDING, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SAGERMANN,L.GAY,W.A.BAASE,B.W.MATTHEWS REVDAT 5 27-OCT-21 1P5C 1 SEQADV REVDAT 4 14-AUG-19 1P5C 1 REMARK REVDAT 3 24-JUL-19 1P5C 1 REMARK REVDAT 2 24-FEB-09 1P5C 1 VERSN REVDAT 1 04-MAY-04 1P5C 0 JRNL AUTH M.SAGERMANN,W.A.BAASE,B.H.MOOERS,L.GAY,B.W.MATTHEWS JRNL TITL RELOCATION OR DUPLICATION OF THE HELIX A SEQUENCE OF T4 JRNL TITL 2 LYSOZYME CAUSES ONLY MODEST CHANGES IN STRUCTURE BUT CAN JRNL TITL 3 INCREASE OR DECREASE THE RATE OF FOLDING. JRNL REF BIOCHEMISTRY V. 43 1296 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 14756565 JRNL DOI 10.1021/BI035702Q REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.SAGERMANN,B.W.MATTHEWS REMARK 1 TITL CRYSTAL STRUCTURES OF A T4-LYSOZYME DUPLICATION-EXTENSION REMARK 1 TITL 2 MUTANT DEMONSTRATES THAT THE HIGHLY CONSERVED BETA-SHEET REMARK 1 TITL 3 REGION HAS LOW INTRINSIC FOLDING PROPENSITY REMARK 1 REF J.MOL.BIOL. V. 316 931 2002 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.2001.5376 REMARK 1 REFERENCE 2 REMARK 1 AUTH L.H.WEAVER,B.W.MATTHEWS REMARK 1 TITL STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME REFINED AT 1.7 A REMARK 1 TITL 2 RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 193 189 1987 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.SAGERMANN,W.A.BAASE,B.W.MATTHEWS REMARK 1 TITL STRUCTURAL CHARACTERIZATION OF AN ENGINEERED TANDEM REPEAT REMARK 1 TITL 2 CONTRASTS THE IMPORTANCE OF CONTEXT AND SEQUENCE IN PROTEIN REMARK 1 TITL 3 FOLDING REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 96 6078 1999 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.96.11.6078 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 22881 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.248 REMARK 3 FREE R VALUE : 0.310 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2324 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 23573 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5264 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 286 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 35.110 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.012 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 13.600; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : 1.700 ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : ENGH & HUBER REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: AMINO TERMINAL METHIONINE RESIDUE NOT REMARK 3 VISIBLE IN DENSITY. REMARK 4 REMARK 4 1P5C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-APR-03. REMARK 100 THE DEPOSITION ID IS D_1000019026. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 170 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : SINGLE SI CRYSTAL REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22893 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07600 REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.08800 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2LZM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 3400, 50MM PHOSPHATE BUFFER, REMARK 280 5% ISOPROPANOL, PH 7.1, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.88150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: PROTEIN IS A MONOMER IN SOLUTION. THE ASYMMETRIC UNIT REMARK 300 CONTAINS 4 MOLECULES. THE REFINEMENT WAS PERFORMED IN THE ABSENCE REMARK 300 OF NCS OPERATORS. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 12 REMARK 465 MET B 12 REMARK 465 MET C 12 REMARK 465 MET D 12 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR A 18 O HOH A 260 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO C 143 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 21 -5.55 -57.49 REMARK 500 ASN A 55 26.15 49.47 REMARK 500 LYS A 135 56.38 -102.31 REMARK 500 PRO B 37 49.95 -78.63 REMARK 500 ARG B 125 59.97 -96.23 REMARK 500 LYS B 135 62.54 -109.52 REMARK 500 LYS D 135 43.10 -91.45 REMARK 500 MET D 168 13.55 -142.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JTM RELATED DB: PDB REMARK 900 DUPLICATION EXTENSION OF THE B-SHEET SEQUENCE OF T4 LYSOZYME REMARK 900 RELATED ID: 1P56 RELATED DB: PDB REMARK 900 DUPLICATION-EXTENSION OF HELIX A OF T4 LYSOZYME REMARK 900 RELATED ID: 262L RELATED DB: PDB REMARK 900 HELIX B TANDEM REPEAT REMARK 900 RELATED ID: 1OYU RELATED DB: PDB REMARK 900 HELIX B TANDEM REPEAT, ALTERNATIVE CONFORMATION REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE LEU 164 WAS DELETED AND SEQUENCE SGGAMNIFEMLRIDE REMARK 999 WAS APPENDED TO THE C-TERMINUS DBREF 1P5C A 12 178 UNP P00720 LYS_BPT4 12 163 DBREF 1P5C B 12 178 UNP P00720 LYS_BPT4 12 163 DBREF 1P5C C 12 178 UNP P00720 LYS_BPT4 12 163 DBREF 1P5C D 12 178 UNP P00720 LYS_BPT4 12 163 SEQADV 1P5C MET A 12 UNP P00720 GLY 12 ENGINEERED MUTATION SEQADV 1P5C THR A 54 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 1P5C ALA A 97 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 1P5C SER A 164 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY A 165 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY A 166 UNP P00720 SEE REMARK 999 SEQADV 1P5C ALA A 167 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET A 168 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASN A 169 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE A 170 UNP P00720 SEE REMARK 999 SEQADV 1P5C PHE A 171 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU A 172 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET A 173 UNP P00720 SEE REMARK 999 SEQADV 1P5C ARG A 175 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE A 176 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASP A 177 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU A 178 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET B 12 UNP P00720 GLY 12 ENGINEERED MUTATION SEQADV 1P5C THR B 54 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 1P5C ALA B 97 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 1P5C SER B 164 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY B 165 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY B 166 UNP P00720 SEE REMARK 999 SEQADV 1P5C ALA B 167 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET B 168 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASN B 169 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE B 170 UNP P00720 SEE REMARK 999 SEQADV 1P5C PHE B 171 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU B 172 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET B 173 UNP P00720 SEE REMARK 999 SEQADV 1P5C ARG B 175 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE B 176 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASP B 177 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU B 178 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET C 12 UNP P00720 GLY 12 ENGINEERED MUTATION SEQADV 1P5C THR C 54 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 1P5C ALA C 97 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 1P5C SER C 164 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY C 165 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY C 166 UNP P00720 SEE REMARK 999 SEQADV 1P5C ALA C 167 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET C 168 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASN C 169 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE C 170 UNP P00720 SEE REMARK 999 SEQADV 1P5C PHE C 171 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU C 172 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET C 173 UNP P00720 SEE REMARK 999 SEQADV 1P5C ARG C 175 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE C 176 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASP C 177 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU C 178 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET D 12 UNP P00720 GLY 12 ENGINEERED MUTATION SEQADV 1P5C THR D 54 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 1P5C ALA D 97 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 1P5C SER D 164 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY D 165 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLY D 166 UNP P00720 SEE REMARK 999 SEQADV 1P5C ALA D 167 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET D 168 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASN D 169 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE D 170 UNP P00720 SEE REMARK 999 SEQADV 1P5C PHE D 171 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU D 172 UNP P00720 SEE REMARK 999 SEQADV 1P5C MET D 173 UNP P00720 SEE REMARK 999 SEQADV 1P5C ARG D 175 UNP P00720 SEE REMARK 999 SEQADV 1P5C ILE D 176 UNP P00720 SEE REMARK 999 SEQADV 1P5C ASP D 177 UNP P00720 SEE REMARK 999 SEQADV 1P5C GLU D 178 UNP P00720 SEE REMARK 999 SEQRES 1 A 167 MET LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 2 A 167 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 3 A 167 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 4 A 167 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 5 A 167 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 6 A 167 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 7 A 167 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 8 A 167 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 9 A 167 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 10 A 167 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 11 A 167 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 12 A 167 THR GLY THR TRP ASP ALA TYR LYS ASN SER GLY GLY ALA SEQRES 13 A 167 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU SEQRES 1 B 167 MET LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 2 B 167 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 3 B 167 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 4 B 167 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 5 B 167 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 6 B 167 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 7 B 167 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 8 B 167 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 9 B 167 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 10 B 167 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 11 B 167 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 12 B 167 THR GLY THR TRP ASP ALA TYR LYS ASN SER GLY GLY ALA SEQRES 13 B 167 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU SEQRES 1 C 167 MET LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 2 C 167 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 3 C 167 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 4 C 167 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 5 C 167 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 6 C 167 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 7 C 167 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 8 C 167 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 9 C 167 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 10 C 167 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 11 C 167 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 12 C 167 THR GLY THR TRP ASP ALA TYR LYS ASN SER GLY GLY ALA SEQRES 13 C 167 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU SEQRES 1 D 167 MET LEU ARG LEU LYS ILE TYR LYS ASP THR GLU GLY TYR SEQRES 2 D 167 TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SER PRO SEQRES 3 D 167 SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS ALA ILE SEQRES 4 D 167 GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP GLU ALA SEQRES 5 D 167 GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA VAL ARG SEQRES 6 D 167 GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL TYR ASP SEQRES 7 D 167 SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE ASN MET SEQRES 8 D 167 VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY PHE THR SEQRES 9 D 167 ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP ASP GLU SEQRES 10 D 167 ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR ASN GLN SEQRES 11 D 167 THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR PHE ARG SEQRES 12 D 167 THR GLY THR TRP ASP ALA TYR LYS ASN SER GLY GLY ALA SEQRES 13 D 167 MET ASN ILE PHE GLU MET LEU ARG ILE ASP GLU FORMUL 5 HOH *286(H2 O) HELIX 1 1 SER A 38 GLY A 51 1 14 HELIX 2 2 THR A 59 ASN A 81 1 23 HELIX 3 3 LYS A 83 LEU A 91 1 9 HELIX 4 4 ASP A 92 GLY A 107 1 16 HELIX 5 5 GLY A 107 GLY A 113 1 7 HELIX 6 6 PHE A 114 GLN A 123 1 10 HELIX 7 7 ARG A 125 ALA A 134 1 10 HELIX 8 8 SER A 136 THR A 142 1 7 HELIX 9 9 THR A 142 GLY A 156 1 15 HELIX 10 10 TRP A 158 LYS A 162 5 5 HELIX 11 11 ASN A 169 GLU A 178 1 10 HELIX 12 12 SER B 38 GLY B 51 1 14 HELIX 13 13 THR B 59 ARG B 80 1 22 HELIX 14 14 LYS B 83 LEU B 91 1 9 HELIX 15 15 ASP B 92 GLY B 107 1 16 HELIX 16 16 GLY B 107 GLY B 113 1 7 HELIX 17 17 PHE B 114 GLN B 123 1 10 HELIX 18 18 ARG B 125 ALA B 134 1 10 HELIX 19 19 SER B 136 THR B 142 1 7 HELIX 20 20 THR B 142 GLY B 156 1 15 HELIX 21 21 TRP B 158 GLY B 165 5 8 HELIX 22 22 ASN B 169 GLU B 178 1 10 HELIX 23 23 SER C 38 GLY C 51 1 14 HELIX 24 24 THR C 59 ARG C 80 1 22 HELIX 25 25 LYS C 83 LEU C 91 1 9 HELIX 26 26 ASP C 92 GLY C 107 1 16 HELIX 27 27 GLY C 107 GLY C 113 1 7 HELIX 28 28 PHE C 114 GLN C 123 1 10 HELIX 29 29 ARG C 125 ALA C 134 1 10 HELIX 30 30 SER C 136 THR C 142 1 7 HELIX 31 31 THR C 142 GLY C 156 1 15 HELIX 32 32 TRP C 158 GLY C 165 5 8 HELIX 33 33 ASN C 169 GLU C 178 1 10 HELIX 34 34 SER D 38 GLY D 51 1 14 HELIX 35 35 THR D 59 ARG D 80 1 22 HELIX 36 36 LYS D 83 LEU D 91 1 9 HELIX 37 37 ASP D 92 GLY D 107 1 16 HELIX 38 38 GLY D 107 GLY D 113 1 7 HELIX 39 39 PHE D 114 GLN D 123 1 10 HELIX 40 40 ARG D 125 LYS D 135 1 11 HELIX 41 41 SER D 136 THR D 142 1 7 HELIX 42 42 THR D 142 GLY D 156 1 15 HELIX 43 43 TRP D 158 GLY D 165 5 8 HELIX 44 44 ASN D 169 GLU D 178 1 10 SHEET 1 A 3 ARG A 14 LYS A 19 0 SHEET 2 A 3 TYR A 25 GLY A 28 -1 O THR A 26 N TYR A 18 SHEET 3 A 3 HIS A 31 THR A 34 -1 O LEU A 33 N TYR A 25 SHEET 1 B 3 TYR B 18 LYS B 19 0 SHEET 2 B 3 TYR B 25 ILE B 27 -1 O THR B 26 N TYR B 18 SHEET 3 B 3 HIS B 31 THR B 34 -1 O HIS B 31 N ILE B 27 SHEET 1 C 3 ARG C 14 LYS C 19 0 SHEET 2 C 3 TYR C 25 GLY C 28 -1 O THR C 26 N TYR C 18 SHEET 3 C 3 HIS C 31 THR C 34 -1 O LEU C 33 N TYR C 25 SHEET 1 D 3 ARG D 14 LYS D 19 0 SHEET 2 D 3 TYR D 25 GLY D 28 -1 O THR D 26 N TYR D 18 SHEET 3 D 3 HIS D 31 THR D 34 -1 O LEU D 33 N TYR D 25 CRYST1 53.758 67.763 94.057 90.00 92.58 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018602 0.000000 0.000838 0.00000 SCALE2 0.000000 0.014757 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010643 0.00000 MASTER 293 0 0 44 12 0 0 6 0 0 0 52 END